Related Experiment Video
Updated: Apr 13, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Pharmacoresistent Partial Epilepsy Secondary to Progressive Inflammatory Poliodystrophy.
Rachel A Kuperman1, Kenneth W Martin2
1Pediatric Neurology, Children's Hospital and Research Center, Oakland, California.
Two children with epilepsy experienced progressive gray matter loss and central nervous system inflammation, suggesting a novel inflammatory brain process. Sequential brain imaging is crucial for diagnosing epilepsy with cortical volume loss in pediatric cases.
Area of Science:
- Neurology
- Neuroinflammation
- Pediatric Epilepsy
Background:
- Epilepsy with progressive cortical volume loss is often linked to energy failure (e.g., mitochondrial disorders) or inflammation, typically in the temporal lobe.
- However, postmortem studies indicate seizures alone do not universally cause cortical volume loss.
Observation:
- Two children presented with extratemporal, pharmacoresistant epilepsy and gradual gray matter volume reduction over years.
- They also showed signs of central nervous system (CNS) inflammation.
Findings:
- Brain imaging and antibody profiles in these patients did not align with known antibody-mediated CNS syndromes like N-methyl-D-aspartate receptor encephalitis.
- This suggests a distinct inflammatory process.
Implications:
- These cases highlight a novel presentation of subacute CNS inflammation associated with epilepsy and progressive cortical volume loss.
- The findings underscore the importance of serial brain imaging in evaluating children with epilepsy and unexplained cortical volume changes.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...